Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) Fixed-Dose Combination (FDC) Compared With Ritonavir-Boosted Atazanavir (ATV/r) Plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Naive Women With Human Immunodeficiency Virus (HIV)-1 Infection (ARIA Study): Analyses by Race Subgroups | Zendy

Debbie Hagins | Zendy; Craig Dietz | Zendy; Mamta K. Jain | Zendy; Cornelius Van Dam | Zendy; Indira Brar | Zendy; Choy Man | Zendy; Jiangxiu Zhou | Zendy; Annie Buchanan | Zendy; Brian Wynne | Zendy; Cindy Vavro | Zendy; Michael Aboud | Zendy; Kimberly Y. Smith | Zendy

Open Access

Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) Fixed-Dose Combination (FDC) Compared With Ritonavir-Boosted Atazanavir (ATV/r) Plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Naive Women With Human Immunodeficiency Virus (HIV)-1 Infection (ARIA Study): Analyses by Race Subgroups

Author(s) -

Debbie Hagins,

Craig Dietz,

Mamta K. Jain,

Cornelius Van Dam,

Indira Brar,

Choy Man,

Jiangxiu Zhou,

Annie Buchanan,

Brian Wynne,

Cindy Vavro,

Michael Aboud,

Kimberly Y. Smith

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofw194.89

Subject(s) - dolutegravir , abacavir , emtricitabine , medicine , atazanavir , pharmacology , ritonavir , lamivudine , fixed dose combination , rilpivirine , virology , raltegravir , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , hepatitis b virus , virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research